Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Malignant rhabdoid tumor is a highly aggressive pediatric neoplasm molecularly characterized by inactivating mutations of the SMARCB1 gene, a potent tumor suppressor and member of the SWI/SNF chromatin remodeling complex. It has been suggested that oncogenesis in SMARCB1-deficient cancers, such as malignant rhabdoid tumors, is driven not by the loss of SWI/SNF function but by an aberrant functioning of the BRG1-containing SWI/SNF complex. Since Brg1 is required for self-renewal and pluripotency of mouse embryonic stem cells, we hypothesized that the human malignant rhabdoid tumors may express pluripotency genes such as SALL4, LIN28, OCT3 and OCT4 (OCT3/4), NANOG, and TCL1. To test this hypothesis, we studied the immunohistochemical expression of SALL4, LIN28, OCT3/4, NANOG, and TCL1 in 11 malignant rhabdoid tumors of the central nervous system (atypical teratoid/rhabdoid tumors) and 5 malignant rhabdoid tumors of the kidney. Of the 16 malignant rhabdoid tumors, 14 (88%) tumors showed robust SALL4 and/or LIN28 expression. No tumor showed any significant OCT3/4, NANOG, or TCL1 expression. Our results suggest that malignant rhabdoid tumors may arise from and/or share features with embryonic stem cells or germ cells.

Original languageEnglish (US)
Pages (from-to)353-359
Number of pages7
JournalPediatric and Developmental Pathology
Volume14
Issue number5
DOIs
StatePublished - 2011

Fingerprint

Rhabdoid Tumor
Embryonic Stem Cells
Neoplasms
Nervous System Neoplasms
Chromatin Assembly and Disassembly
Germ Cells
Genes
Carcinogenesis
Central Nervous System
Pediatrics
Kidney
Mutation

Keywords

  • Atypical teratoid/rhabdoid tumor
  • Central nervous system
  • Kidney
  • LIN28
  • Malignant rhabdoid tumor
  • SALL4

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pathology and Forensic Medicine

Cite this

Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. / Deisch, Jeremy; Raisanen, Jack M; Rakheja, Dinesh.

In: Pediatric and Developmental Pathology, Vol. 14, No. 5, 2011, p. 353-359.

Research output: Contribution to journalArticle

@article{af1063e839c241bc86fbb123ecc542d2,
title = "Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors",
abstract = "Malignant rhabdoid tumor is a highly aggressive pediatric neoplasm molecularly characterized by inactivating mutations of the SMARCB1 gene, a potent tumor suppressor and member of the SWI/SNF chromatin remodeling complex. It has been suggested that oncogenesis in SMARCB1-deficient cancers, such as malignant rhabdoid tumors, is driven not by the loss of SWI/SNF function but by an aberrant functioning of the BRG1-containing SWI/SNF complex. Since Brg1 is required for self-renewal and pluripotency of mouse embryonic stem cells, we hypothesized that the human malignant rhabdoid tumors may express pluripotency genes such as SALL4, LIN28, OCT3 and OCT4 (OCT3/4), NANOG, and TCL1. To test this hypothesis, we studied the immunohistochemical expression of SALL4, LIN28, OCT3/4, NANOG, and TCL1 in 11 malignant rhabdoid tumors of the central nervous system (atypical teratoid/rhabdoid tumors) and 5 malignant rhabdoid tumors of the kidney. Of the 16 malignant rhabdoid tumors, 14 (88{\%}) tumors showed robust SALL4 and/or LIN28 expression. No tumor showed any significant OCT3/4, NANOG, or TCL1 expression. Our results suggest that malignant rhabdoid tumors may arise from and/or share features with embryonic stem cells or germ cells.",
keywords = "Atypical teratoid/rhabdoid tumor, Central nervous system, Kidney, LIN28, Malignant rhabdoid tumor, SALL4",
author = "Jeremy Deisch and Raisanen, {Jack M} and Dinesh Rakheja",
year = "2011",
doi = "10.2350/10-09-0902-OA.1",
language = "English (US)",
volume = "14",
pages = "353--359",
journal = "Pediatric and Developmental Pathology",
issn = "1093-5266",
publisher = "Society for Pediatric Pathology",
number = "5",

}

TY - JOUR

T1 - Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors

AU - Deisch, Jeremy

AU - Raisanen, Jack M

AU - Rakheja, Dinesh

PY - 2011

Y1 - 2011

N2 - Malignant rhabdoid tumor is a highly aggressive pediatric neoplasm molecularly characterized by inactivating mutations of the SMARCB1 gene, a potent tumor suppressor and member of the SWI/SNF chromatin remodeling complex. It has been suggested that oncogenesis in SMARCB1-deficient cancers, such as malignant rhabdoid tumors, is driven not by the loss of SWI/SNF function but by an aberrant functioning of the BRG1-containing SWI/SNF complex. Since Brg1 is required for self-renewal and pluripotency of mouse embryonic stem cells, we hypothesized that the human malignant rhabdoid tumors may express pluripotency genes such as SALL4, LIN28, OCT3 and OCT4 (OCT3/4), NANOG, and TCL1. To test this hypothesis, we studied the immunohistochemical expression of SALL4, LIN28, OCT3/4, NANOG, and TCL1 in 11 malignant rhabdoid tumors of the central nervous system (atypical teratoid/rhabdoid tumors) and 5 malignant rhabdoid tumors of the kidney. Of the 16 malignant rhabdoid tumors, 14 (88%) tumors showed robust SALL4 and/or LIN28 expression. No tumor showed any significant OCT3/4, NANOG, or TCL1 expression. Our results suggest that malignant rhabdoid tumors may arise from and/or share features with embryonic stem cells or germ cells.

AB - Malignant rhabdoid tumor is a highly aggressive pediatric neoplasm molecularly characterized by inactivating mutations of the SMARCB1 gene, a potent tumor suppressor and member of the SWI/SNF chromatin remodeling complex. It has been suggested that oncogenesis in SMARCB1-deficient cancers, such as malignant rhabdoid tumors, is driven not by the loss of SWI/SNF function but by an aberrant functioning of the BRG1-containing SWI/SNF complex. Since Brg1 is required for self-renewal and pluripotency of mouse embryonic stem cells, we hypothesized that the human malignant rhabdoid tumors may express pluripotency genes such as SALL4, LIN28, OCT3 and OCT4 (OCT3/4), NANOG, and TCL1. To test this hypothesis, we studied the immunohistochemical expression of SALL4, LIN28, OCT3/4, NANOG, and TCL1 in 11 malignant rhabdoid tumors of the central nervous system (atypical teratoid/rhabdoid tumors) and 5 malignant rhabdoid tumors of the kidney. Of the 16 malignant rhabdoid tumors, 14 (88%) tumors showed robust SALL4 and/or LIN28 expression. No tumor showed any significant OCT3/4, NANOG, or TCL1 expression. Our results suggest that malignant rhabdoid tumors may arise from and/or share features with embryonic stem cells or germ cells.

KW - Atypical teratoid/rhabdoid tumor

KW - Central nervous system

KW - Kidney

KW - LIN28

KW - Malignant rhabdoid tumor

KW - SALL4

UR - http://www.scopus.com/inward/record.url?scp=84855369481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855369481&partnerID=8YFLogxK

U2 - 10.2350/10-09-0902-OA.1

DO - 10.2350/10-09-0902-OA.1

M3 - Article

C2 - 21417895

AN - SCOPUS:84855369481

VL - 14

SP - 353

EP - 359

JO - Pediatric and Developmental Pathology

JF - Pediatric and Developmental Pathology

SN - 1093-5266

IS - 5

ER -